Armen Asatryan, MD
AbbVie
4
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming-Lung Yu, MD, PhD
Kaohsiung Medical University
Shared therapeutic areas:
Mostafa Gabr, MD
Cairo University
Shared therapeutic areas:
Wahid Doss, MD
Cairo University
Shared therapeutic areas:
Mohamed A Afify, MD
Cairo University
Shared therapeutic areas:
Gamal Sheha, MD
Cairo University
Shared therapeutic areas:
Noaman Al-Garem, MD
Cairo University
Shared therapeutic areas:
Pei-Jer Chen, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Shih-Jer Hsu, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Gamal Esmat, MD
Cairo University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
Bioavailability of ABT-450 and ABT-267 With Ritonavir
A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection
All 4 trials loaded